Replimune Group Inc — Quarterly Financial Statistics (NASDAQ:REPL) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities -50.71 M-53.73 M-77.02 M-81.21 M-65.95 M -277.91 M Cash from investing activities -46.32 M-7.7 M65.05 M84.17 M75.12 M 216.64 M Cash from financing activities 155.93 M-132 K-158 K324 K10.45 M 10.48 M Free cash flow -52.51 M-54.87 M-79.76 M-82.56 M-66.09 M -283.27 M

ニュース

Replimune Stock: Multiple Shots On Goal But A High Risk Binary Approaches (NASDAQ:REPL)

Wall Street Analysts Predict a 65.72% Upside in Replimune Group (REPL): Here's What You Should Know

Here's Why Replimune Stock Skyrockets Nearly 131% in 3 Months

Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)

ショートリスト — 現在最も空売りされている銘柄トップ10

Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3

The Short List — Top 10 Most Shorted Stocks Right Now - Lucid Group (NASDAQ:LCID)

Iovance Biotherapeutics: Several Positives, But Competition Still Threatens (NASDAQ:IOVA)

キャンター・フィッツジェラルド社、レプリミューン・グループ株に対する「オーバーウェイト」評価を維持

Cantor Fitzgerald reiterates Overweight rating on Replimune Group stock

レプリミューン、SITCでメラノーマ治療の良好なデータを報告

Replimune reports positive data for melanoma treatment at SITC 2025